QA: Carisma Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2019_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 15.56275683926265, 'aggregate_val': 141065000, 'exp_sum': 8517000, 'exp_to_value': {'LiabilitiesCurrent': 8517000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 51,756,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 321,000
3 remainder_Assets 20,000
4 LiabilitiesCurrent 6,113,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,874,351
9 ResearchAndDevelopmentExpense 14,087,517
10 remainder_Expenses 8,835,747
11 remainder_Revenues 0
12 remainder_NetIncome 758,631
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 111,561,000
1 Liabilities 6,113,000
2 Expenses 33,797,615
3 Revenues 0
4 StockholdersEquity 105,448,000
5 NetIncome -33,038,984
6 ComprehensiveNetIncome -33,038,984
7 BaseVar 76,115,123
8 EconomicCapitalRatiobeforeLimitedLiability 3.35
9 EconomicCapitalRatio 3.92

Edgar->Model Mapping

Feature Distribution

Change over Time